Jared Wolff, Zach McLellan, Jack Allen, and Maha Elsayed discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast.
Special thanks to Kevin (Kayj) Shannon for joining us on the podcast this week! Kayj is a cardiovascular and metabolic diseases analyst for Datamonitor Healthcare who is based in San Diego, CA.
Epidiolex’s role as a cannabinoid treatment for pediatric epilepsy (0:36)
Puma Biotechnology's niratinib upcoming advisory committee meeting (7:15)
CRL issued to Eli Lilly and Incyte for baricitinib in rheumatoid arthritis (14:27)
Discussion of key second quarter market catalysts for Radius Health, Intercept Pharmaceuticals, FibroGen, and Cara Therapeutics (23:21)
To learn more about Datamonitor Healthcare and our offerings, vist: https://pharmaintelligence.informa.com/products-and-services/data-and-analysis/datamonitor-healthcare
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: